Loading stock data…
CC
$20.26-0.48 (-2.31%)
Market ClosedLast close Jun 29
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
The Chemours Company in the Basic Materials sector is trading at $20.26 with a market capitalization of $3.3B. Wall Street consensus targets $26.33 (9 analysts), implying a +30.0% move over the next 12 months. The stock is currently 29% below its 52-week high of $28.67, remaining 16.1% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +30.0% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.38B↑ | $1.33B↓ | $1.50B↓ | $1.61B↑ | $1.37B |
| Gross Profit | $212.00M↑ | $156.00M↓ | $233.00M↓ | $278.00M↑ | $236.00M |
| Operating Income | $39.00M↑ | -$5.00M↓ | $93.00M↑ | -$187.00M↓ | $78.00M |
| Net Income | -$29.00M↑ | -$61.00M↓ | $60.00M↑ | -$381.00M↓ | -$5.00M |
Peer Comparison
Fundamentals
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advan...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.30B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.33%
ROE
Average efficiency. Growth may require heavy reinvestment.
-191.16%
Volume
Today's trading volume
2.82M
Recent News
Chemours will pay $450M over forever chemicals — but North Carolina calls the deal 'an insult'
PFAs are wreaking havoc and Chemours will have to pay for it.
JPMorgan Just Raised Its View on Chemours (CC)—What Changed?
With an upside potential of 25.65% according to analysts, The Chemours Company (NYSE:CC) is among the 10 Most Promising Hydrogen and Fuel Cell Stocks According to Analysts. On May 21, JPMorgan analyst Jeffrey Zekauskas raised the firm’s price target for The Chemours Company (NYSE:CC) to $22 from $17 while maintaining a Neutral rating on the shares. The upward revision reflects an improved […]
PRM Stock Outlook as New Fire Contracts Improve Earnings Visibility
PRM is gaining earnings visibility as new five-year fire contracts, annual escalators and a growing services base reduce reliance on any single fire season.
Chemours (CC) Surges 6.1%: Is This an Indication of Further Gains?
Chemours (CC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Chemours to pay $450M in first federal "forever chemicals" settlement
Chemical maker Chemours allegedly discharged chemicals linked to cancer and other health conditions in three states.